Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma (Q44288471)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma |
scientific article published in April 2004 |
Statements
1 reference
Cancer and Leukemia Group B 90206: A randomized phase III trial of interferon-alpha or interferon-alpha plus anti-vascular endothelial growth factor antibody (bevacizumab) in metastatic renal cell carcinoma (English)
1 reference
Cancer and Leukemia Group B
1 reference
Eric J Small
1 reference
Susan Halabi
1 reference
Brian I Rini
1 reference
John Taylor
1 reference
Richard L Schilsky
1 reference
1 April 2004
1 reference
1 reference
10
1 reference
8
1 reference
2584-2586
1 reference
Identifiers
1 reference
1 reference